Akèy › Kadiyomiopati Ipertrofik › Massachusetts
Etid klinik pou Kadiyomiopati Ipertrofik nan Massachusetts
6 etid pou Kadiyomiopati Ipertrofik ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05489705Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Tufts Medical Center, Boston
- Boston Medical Center, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT06034405A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Boston
- Imbria Investigational Site, Burlington
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT07023614A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Boston Children's Hospital, Boston
Ap rekriteFaz 2
Laj 8 ak plis · Gason · Mizajou May 4, 2026 · NCT06092034HCMR Re-Imaging Study
- Brigham & Women's Hospital, Boston
- Tufts Medical Center, Medford
Ap rekriteEtid obsèvasyon
Laj 18 a 65 · Tout sèks · Mizajou Mar 18, 2026 · NCT07054073Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
- Analysis Group Inc., Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Nov 7, 2024 · NCT06551129Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.